EUCTR2021-004727-33-SE进行中（未招募）1 期
A Phase 3, Open-Label Extension of COURAGE-ALS(CY 5031) - COURAGE-ALS OLE
Cytokinetics Inc0 个研究点目标入组 400 人开始时间: 2022年10月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Able to comprehend and willing to sign an Informed Consent Form (ICF). If patient is able to comprehend, but non-written consent is given, an impartial witness of the patient must sign the ICF form
- •Completed dosing in CY 5031
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 270
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 130
排除标准
- •Has taken an investigational study drug (other than reldesemtiv) prior to dosing, within 30 days or five half-lives of the prior agent, whichever is greater
研究者
相似试验
进行中（未招募）
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic LateralSclerosis (ALS) and who have already participated in clinical study CY 5031.Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-004727-33-NLCytokinetics Inc400
进行中（未招募）
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic LateralSclerosis (ALS) and who have already participated in clinical study CY 5031.Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-004727-33-DKCytokinetics Inc400
进行中（未招募）
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic Lateral Sclerosis (ALS) and who have already participated in clinical study CY 5031.EUCTR2021-004727-33-PTCytokinetics Inc400
招募中
1 期
A Clinical Study for patients who are diagnosed with Amyotrophic Lateral Sclerosis (ALS) and who have already participated in clinical study CY 5031.Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-004727-33-ITCYTOKINETICS, INC.400
已完成
3 期
A PHASE 3, OPEN-LABEL EXTENSION OF COURAGE-ALS (CY 5031)NL-OMON53955Cytokinetics10